HEALTH: The Antibiotic Resistance Crisis and Its Historical Parallel Since Fleming's 1928 discovery of penicillin, antibiotics have prevented an estimated 200+ million deaths globally, yet overuse has created a cascade problem: the CDC estimates 2.8 million antibiotic-resistant infections annually in the US alone, with 35,000+ deaths. Resistant tuberculosis strains now require 20+ months of treatment with toxic drugs costing $15,000-$20,000 per patient, compared to standard TB therapy's 6-month course. This mirrors the pre-antibiotic era's mortality rates—a 1900s surgical patient faced 30-40% infection death risk—making modern resistance a public health regression that directly threatens routine surgeries, cancer treatment, and emergency care. Why it matters: Without intervention, economists project resistant infections could cause 10 million annual deaths by 2050 and reduce global GDP by 3.8%, making this as consequential as climate change to civilization's trajectory.